Study Details
Understanding Insurance Barriers to GLP-1 Medications for Weight Management
(IRB#: IRB_00197900)
We are doing a study to understand how people get access to GLP-1 medications used for weight management, such as semaglutide or tirzepatide. Many people face insurance problems like high costs, denials, or delays. We want to learn what these experiences are like and how they affect care. We will interview adults who have tried to get a GLP-1 medication and health care providers who prescribe them. The goal is to better understand real barriers and help improve future access to these medications. Interviews take about 20-25 minutes and can be done by Zoom or phone.
- All genders
- Over 18 years old
- Healthy Volunteers
- From Home
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Healthy Volunteers
Location: From Home
Inclusion Criteria
- Adults 18 or older
- Have tried to access or prescribe a GLP-1 medication for weight management
- Able to complete a 30-minute interview in English
Exclusion Criteria
- Under age 18
- Unable to participate in English
- Have never used, attempted to use, or prescribed a GLP-1 medication
Will I be paid for my time?
Yes
IRB#: IRB_00197900
PI: Elvis Duru
Department: PHARMACOTHERAPY
Approval Date: 2026-02-06 20:50:00
Study Categories: Diabetes Studies, Heart Studies, Weight Loss Studies
Specialties: Endocrinology & Metabolism
I am Interested